22(r)-hydroxycholesterol

22(r)-hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 22(r)-hydroxycholesterol is associated with abnormalities such as Transient Ischemic Attack, Still, Neurodegenerative Disorders and Senile Plaques. The involved functions are known as Binding (Molecular Function), inhibitors, mRNA Expression, Gene Expression and Transcription, Genetic. 22(r)-hydroxycholesterol often locates in Blood, Protoplasm, Extracellular, Cytosol and Cytoplasm. The associated genes with 22(r)-hydroxycholesterol are CCL2 gene, IL8RB gene, CALCA gene and GRM5 gene. The related lipids are 22-hydroxycholesterol, Lipopolysaccharides, 15-deoxyprostaglandin J2 and 7-ketocholesterol.

Cross Reference

Introduction

To understand associated biological information of 22(r)-hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22(r)-hydroxycholesterol?

22(r)-hydroxycholesterol is suspected in Neurodegenerative Disorders, Transient Ischemic Attack, Senile Plaques and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22(r)-hydroxycholesterol

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Total 1

PubChem Associated disorders and diseases

What pathways are associated with 22(r)-hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22(r)-hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22(r)-hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22(r)-hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22(r)-hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22(r)-hydroxycholesterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22(r)-hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 161
Authors Title Published Journal PubMed Link
Yoshida K et al. Long-term feeding of hydroalcoholic extract powder of Lepidium meyenii (maca) enhances the steroidogenic ability of Leydig cells to alleviate its decline with ageing in male rats. 2018 Andrologia pmid:28295471
Yi M et al. Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma. 2017 Toxicol. Appl. Pharmacol. pmid:28729181
Li J et al. Feedback inhibition of CREB signaling by p38 MAPK contributes to the negative regulation of steroidogenesis. 2017 Reprod. Biol. Endocrinol. pmid:28302174
Venugopal S et al. Plasma Membrane Origin of the Steroidogenic Pool of Cholesterol Used in Hormone-induced Acute Steroid Formation in Leydig Cells. 2016 J. Biol. Chem. pmid:27815506
Kim H et al. 22(R)-hydroxycholesterol induces HuR-dependent MAP kinase phosphatase-1 expression via mGluR5-mediated Ca(2+)/PKCα signaling. 2016 Biochim. Biophys. Acta pmid:27206966
Ceroi A et al. The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. 2016 Haematologica pmid:26635040
Huwait EA et al. Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages. 2015 J. Cell. Biochem. pmid:25752819
Newby EA et al. Adrenocorticotropic Hormone and PI3K/Akt Inhibition Reduce eNOS Phosphorylation and Increase Cortisol Biosynthesis in Long-Term Hypoxic Ovine Fetal Adrenal Cortical Cells. 2015 Reprod Sci pmid:25656500
Na TY et al. 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα. 2015 J. Pathol. pmid:25557254
Davydov R et al. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies. 2015 Biochemistry pmid:26603348
Trompier D et al. Regulation of the adrenoleukodystrophy-related gene (ABCD2): focus on oxysterols and LXR antagonists. 2014 Biochem. Biophys. Res. Commun. pmid:24480443
Wang JM et al. 22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARγ-LXRα-ABCA1 pathway in cholesterosis of the gallbladder. 2014 Biochem. Biophys. Res. Commun. pmid:24704452
Gondcaille C et al. LXR antagonists induce ABCD2 expression. 2014 Biochim. Biophys. Acta pmid:24239766
Slominski AT et al. In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. 2014 Mol. Cell. Endocrinol. pmid:24382416
Soodgupta D et al. Modulation of LXR-α and the effector genes by Ascorbic acid and Statins in psoriatic keratinocytes. 2014 Mol. Cell. Biochem. pmid:25283515
Mao D et al. ATF3 expression in the corpus luteum: possible role in luteal regression. 2013 Mol. Endocrinol. pmid:24196350
Høgmoen Åstrand OA et al. (2S,3S)-2,6-dimethylheptane-1,3-diol, the oxygenated side chain of 22(S)-hydroxycholestrol, and its synthetic precursor (R)-4-benzyl-3-[(2R,3S)-3-hydroxy-2,6-dimethylheptanoyl]-1,3-oxazolidin-2-one. 2013 Acta Crystallogr C pmid:23744388
Raccosta L et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. 2013 J. Exp. Med. pmid:23897983
Schaffer S et al. Stereo specific platelet inhibition by the natural LXR agonist 22(R)-OH-cholesterol and its fluorescence labelling with preserved bioactivity and chiral handling in macrophages. 2013 Biochem. Pharmacol. pmid:23665353
Olala LO et al. A role for phospholipase D in angiotensin II-induced protein kinase D activation in adrenal glomerulosa cell models. 2013 Mol. Cell. Endocrinol. pmid:23178798
El Roz A et al. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. 2012 Anticancer Res. pmid:22753765
Papadopoulos V and Lecanu L Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties. 2012 J. Neuroendocrinol. pmid:21623958
Hessvik NP et al. The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. 2012 J. Steroid Biochem. Mol. Biol. pmid:22051079
Lecanu L et al. A steroid isolated from the water mold Achlya heterosexualis induces neurogenesis in vitro and in vivo. 2012 Steroids pmid:22138207
García MM et al. Cisplatin inhibits testosterone synthesis by a mechanism that includes the action of reactive oxygen species (ROS) at the level of P450scc. 2012 Chem. Biol. Interact. pmid:22940207
Kittayaruksakul S et al. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule. 2012 Am. J. Physiol. Renal Physiol. pmid:22169006
Tranheim Kase E et al. Dietary supplementation with 22-S-hydroxycholesterol to rats reduces body weight gain and the accumulation of liver triacylglycerol. 2012 Lipids pmid:22426832
Valbuena-Diez AC et al. Oxysterol-induced soluble endoglin release and its involvement in hypertension. 2012 Circulation pmid:23110859
Soodvilai S et al. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells. 2012 Am. J. Physiol. Renal Physiol. pmid:23077096
Kumar R et al. Altered levels of LXR-α: crucial implications in the pathogenesis of vitiligo. 2012 Exp. Dermatol. pmid:23163651
Ortega I et al. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. 2012 Biol. Reprod. pmid:21918126
Cruz-Garcia L et al. Regulation of LXR by fatty acids, insulin, growth hormone and tumor necrosis factor-α in rainbow trout myocytes. 2011 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:21635958
Mast N et al. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. 2011 J. Biol. Chem. pmid:21159775
Escobar JC et al. The human placenta expresses CYP17 and generates androgens de novo. 2011 J. Clin. Endocrinol. Metab. pmid:21307141
Mastrocola R et al. Dysregulation of SREBP2 induces BACE1 expression. 2011 Neurobiol. Dis. pmid:21726644
Aye IL et al. Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. 2011 Placenta pmid:21208656
Chuu CP and Lin HP Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. 2010 Anticancer Res. pmid:20944148
Matsushita K et al. Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. 2010 J. Biol. Chem. pmid:20118482
Chen W et al. Testosterone synthesized in cultured human SZ95 sebocytes derives mainly from dehydroepiandrosterone. 2010 Exp. Dermatol. pmid:20337700
Adachi T et al. Transport-metabolism interplay: LXRalpha-mediated induction of human ABC transporter ABCC2 (cMOAT/MRP2) in HepG2 cells. 2009 Nov-Dec Mol. Pharm. pmid:19588995
Demerjian M et al. Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. 2009 Exp. Dermatol. pmid:19236478
Arikan S and Yigit AA Effects of cholesterol and cAMP on progesterone production in cultured luteal cells isolated from pseudopregnant cat ovaries. 2009 Anim. Reprod. Sci. pmid:19135321
Hynynen R et al. OSBP-related protein 2 is a sterol receptor on lipid droplets that regulates the metabolism of neutral lipids. 2009 J. Lipid Res. pmid:19224871
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Minagawa H et al. Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture. 2009 J. Neurosci. Res. pmid:19326444
Morello F et al. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. 2009 Atherosclerosis pmid:19426978
Qu JH et al. Fenvalerate inhibits progesterone production through cAMP-dependent signal pathway. 2008 Toxicol. Lett. pmid:18053657
Dodo K et al. Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. 2008 Bioorg. Med. Chem. pmid:18343126
Bates SR et al. Expression and biological activity of ABCA1 in alveolar epithelial cells. 2008 Am. J. Respir. Cell Mol. Biol. pmid:17884990
Ouimet M et al. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux. 2008 Arterioscler. Thromb. Vasc. Biol. pmid:18369155